Teleperformance Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Teleperformance heeft een totaal eigen vermogen van €4.2B en een totale schuld van €4.7B, wat de schuld-eigenvermogensverhouding op 110.2% brengt. De totale activa en totale passiva bedragen respectievelijk €12.2B en €7.9B. De EBIT Teleperformance is €1.1B waardoor de rentedekking 5.6 is. Het heeft contanten en kortetermijnbeleggingen van €996.0M.

Belangrijke informatie

110.2%

Verhouding schuld/eigen vermogen

€4.68b

Schuld

Rente dekkingsratio	5.6x
Contant	€996.00m
Aandelen	€4.25b
Totaal verplichtingen	€7.93b
Totaal activa	€12.18b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €3.8B ) 0J6X } overtreffen de korte termijn passiva ( €3.1B ).

Langlopende schulden: De kortetermijnactiva van 0J6X ( €3.8B ) dekken de langetermijnschulden ( €4.9B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 86.7% ) 0J6X wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 0J6X is de afgelopen 5 jaar gestegen van 109.2% naar 110.2%.

Schuldendekking: De schuld van 0J6X wordt goed gedekt door de operationele kasstroom ( 33.2% ).

Rentedekking: De rentebetalingen op de schuld van 0J6X worden goed gedekt door EBIT ( 5.6 x dekking).

Teleperformance Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Teleperformance SE Confirms Earnings Guidance for the Year 2024

Investor sentiment improves as stock rises 15%

First half 2024 earnings released: EPS: €4.85 (vs €4.64 in 1H 2023)

Upcoming dividend of €3.85 per share

Investor sentiment improves as stock rises 17%

Teleperformance Se Provides Earnings Guidance for the Full Year 2024

Teleperformance SE to Report First Half, 2024 Results on Jul 30, 2024

New minor risk - Financial position

Full year 2023 earnings released: EPS: €10.27 (vs €10.95 in FY 2022)

Teleperformance SE Recommends Dividend for 2023, Payable on May 30, 2024

Investor sentiment deteriorates as stock falls 22%

Teleperformance Se Announces to Appoint Bhupender Singh as Sole Chief Executive Officer, Starting January 1, 2026

Teleperformance Launches Digital Services Arm, TP Infinity, to Better Serve Clients Globally Through Consulting, Design and System Integration Services

Investor sentiment improves as stock rises 16%

New minor risk - Shareholder dilution

Teleperformance SE, Annual General Meeting, May 23, 2024

Teleperformance SE to Report Fiscal Year 2023 Results on Feb 28, 2024

Investor sentiment deteriorates as stock falls 17%

Teleperformance Launches TP Configuration, an Ai-Driven Platform to Enhance Service Delivery

Teleperformance Joins the AI Lighthouse Program

Teleperformance Launches AI maturity Assessment Toolkit to Help Companies Evaluate Strategies for AI Success

Teleperformance SE (ENXTPA:TEP) announces an Equity Buyback for €500 million worth of its shares.

First half 2023 earnings released: EPS: €4.64 (vs €4.67 in 1H 2022)

Teleperformance SE Announces Executive Changes

Teleperformance SE Appoints Bhupender Singh as Deputy Chief Executive Officer

Teleperformance Implements AI Solutions Leveraging ServiceNow Platform

Accenture, Teleperformance, Blackstone, BPEA EQT, KKR, Carlyle, Apax and Warburg Pincus Reportedly Interests for Potential Acquisition of Everise

Teleperformance and Blackstone Reportedly Plans Separate Bids for Everise Holdings

Bronstein, Gewirtz & Grossman, LLC Notifies Teleperformance Se Investors of Class Action and to Actively Participate

Investor sentiment deteriorates as stock falls 17%

Upcoming dividend of €3.85 per share at 1.8% yield

Now 25% undervalued after recent price drop

Now 21% undervalued

Full year 2022 earnings released: EPS: €10.95 (vs €9.48 in FY 2021)

Teleperformance SE, Annual General Meeting, Apr 13, 2023

Teleperformance SE (ENXTPA:TEP) commences an Equity Buyback for 5% of its issued share capital, for €2,936.88 million, under the authorization approved on April 14, 2022.

Investor sentiment deteriorated over the past week

Teleperformance SE to Report Fiscal Year 2022 Results on Feb 16, 2023

Teleperformance SE (ENXTPA:TEP) acquired PSG Global Solutions LLC from its management and private investors at an enterprise value of $300 million.

Teleperformance Appoints Anish Mukker as CEO for India Operations

First half 2022 earnings released

Teleperformance SE Confirms Revenue Guidance for the Year 2022

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Upcoming dividend of €3.30 per share

Teleperformance SE Approves Dividend, Payable on April 28, 2022

Teleperformance SE to Report First Half, 2022 Results on Jul 28, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Teleperformance SE Provides Earnings Guidance for the Year 2022 and 2025

Teleperformance SE (ENXTPA:TEP) agreed to acquire Senture, LLC from Kingswood Capital Management, LLC for an enterprise value of $400 million.

Carlyle Group Emerges as the Frontrunner to Acquire Hexaware Technologies from BPEA

First half 2021 earnings released: EPS €4.34 (vs €1.07 in 1H 2020)

Teleperformance SE (ENXTPA:TEP) completed the acquisition of West Health Advocate Solutions, Inc. from Intrado Corporation.

Upcoming dividend of €2.40 per share

Teleperformance SE Revises Revenue Guidance for the Full Year of Fiscal 2021

Full year 2020 earnings released: EPS €5.52 (vs €6.87 in FY 2019)

Revenue beats expectations

Teleperformance SE, Annual General Meeting, Apr 22, 2021

New 90-day high: €295

New 90-day high: €290

Teleperformance SE to Report Q1, 2021 Results on Apr 22, 2021

Teleperformance SE (ENXTPA:TEP) entered into a definitive agreement to acquire West Health Advocate Solutions, Inc. from Intrado Corporation for enterprise value of $690 million.

New 90-day high: €266

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven